Back to Search Start Over

MA16.03 Tremelimumab plus Durvalumab Prior to Chemoradiotherapy in Unresectable Locally Advanced NSCLC, the Induction Trial.

Authors :
Smeenk, M.M.
van Diessen, J.N.A.
Boellaard, T.N.
Hartemink, K.J.
de Vries, J.F.
Badrising, S.K.
Wondergem, M.
Wittenberg, R.
Monkhorst, K.
van den Heuvel, M.M.
Theelen, W.S.M.E.
Source :
Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS157-S157, 1p
Publication Year :
2023

Details

Language :
English
ISSN :
15560864
Volume :
18
Issue :
11
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
173322826
Full Text :
https://doi.org/10.1016/j.jtho.2023.09.229